We’re advancing the frontiers of respiratory medicine by aiming to make a difference for patients beyond just symptom control. We are working to: - Protect people from infections and the associated complications, - Prevent deterioration, exacerbations, lung damage and disease progression, - Treat daily symptoms to provide optimal relief and make clinical remission a reality for as many people as possible with severe asthma. Find out more 👇 https://gsk.to/44Hltnp #ATS2024
About us
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
- Website
-
http://www.gsk.com
External link for GSK
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Brentford, Middlesex
- Type
- Public Company
- Specialties
- Pharmaceutical products and Vaccines
Locations
Employees at GSK
Updates
-
An estimated 5 million people worldwide are living with #lupus – a chronic autoimmune disease that can lead to permanent damage of major organs, including the skin, heart, or kidneys. People living with lupus can experience more severe disease flares and faster disease progression if their condition goes unmanaged and if intervention isn’t timely. This #WorldLupusDay, help shine a light on the lupus community, and learn about the importance of talking with your doctor about living with lupus so you don’t have to face these challenges alone. Learn more: https://bit.ly/3PZpAFp #MakeLupusVisible #LupusAwareness
-
This World Ovarian Cancer Day, we stand in solidarity with the thousands of women who are diagnosed with this disease each year. We remain committed to getting ahead of ovarian cancer and exploring the science behind developing new treatment options for this community. Test your knowledge of ovarian cancer with this poll: #WOCD24 #NoWomanLeftBehind
This content isn’t available here
Access this content and more in the LinkedIn app
-
We need to listen to the people who experience the impact of #asthma every day. Not just on #WorldAsthmaDay. That’s why we’ve listened to Joelle’s experience living with #SevereAsthma, which inspires us in our everyday commitment to help as many people as possible to achieve clinical remission and be free from exacerbations, daily symptoms and the need for oral-corticosteroids. Learn more about the goal of clinical remission in severe asthma: https://gsk.to/3y4MJQB
-
Prevention is the best investment for people, health systems and economies. That’s why we’re using our science and technology to prevent and change the course of disease – from vaccines to help protect all stages of life to getting ahead of diseases like severe asthma and HIV. Realising the potential of prevention needs partnership. So, we’re excited to be the founding partner in the Milken Institute’s new Project Prevent initiative. This will bring together experts from across different sectors, including health and finance, to research and test out new ways to accelerate investment in, and access to, preventative healthcare. #MIGlobal Find out more from Milken: https://gsk.to/3Wvydv7
-
Ovarian cancer is the 8th most common cancer for women worldwide but diagnosing it can be challenging. By recognising early signs and symptoms, those at risk may reach an accurate diagnosis sooner. At GSK, we are dedicated to improving outcomes for the ovarian cancer community. Learn more about our research: https://gsk.me/3UHx9Di #WOCD2024 #NoWomanLeftBehind
-
Get to know our #TargetTheFuture grant recipient: Cancer Support Community! Their Multiple Myeloma Digital Engagement Initiative empowers underserved patients and helps bridge the digital divide for people without internet access. Their platform connects patients and caregivers with a range of resources, including access to telehealth services, #multiplemyeloma education and mental wellness tools. Learn more: www.targetthefuturemm.com #AheadTogether
-
News for #Investors and #Media We’ve announced our strong Q1 2024 results. Swipe to review our key highlights. For more insights, visit us at https://www.gsk.com/en-gb/. $GSK
-
News for #Investors and #Media Explore our Q1 2024 figures at a glance. https://gsk.to/3Un091R. $GSK
-
News for #Investors and #Media Hear our CEO Emma Walmsley talk about our strong Q1 performance and learn more about our upgraded outlooks for the year. For more, see https://www.gsk.com/en-gb/ $GSK #Q1Results